Pharmaceutical
Technology
Health

Agios

$46.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.53 (-5.13%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours

Why Robinhood?

You can buy or sell Agios and other stocks, options, ETFs, and crypto commission-free!

About AGIO

Agios Pharmaceuticals, Inc. Common Stock, also called Agios, is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. Read More It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Employees
482
Headquarters
Cambridge, Massachusetts
Founded
2007
Market Cap
2.74B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
601.31K
High Today
$49.42
Low Today
$46.52
Open Price
$49.42
Volume
882.90K
52 Week High
$93.98
52 Week Low
$41.63

Collections

Pharmaceutical
Technology
Health
Biotechnology
2013 IPO
US
North America

AGIO News

Yahoo FinanceJun 18

Agios Catches Eye: Stock Jumps 5.4%

22

AGIO Earnings

-$1.81
-$1.60
-$1.40
-$1.19
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 1, Pre-Market

More AGIO News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.